| # | Drug | Count |
|---|---|---|
| 0 | ERLOTINIB HYDROCHLORIDE | 12 |
| 1 | CELECOXIB | 10 |
| 2 | CIDOFOVIR ANHYDROUS | 8 |
| 3 | ERLOTINIB | 7 |
| 4 | BEVACIZUMAB | 4 |
| 5 | FINGOLIMOD HCL | 4 |
| 6 | METHOTREXATE SODIUM | 4 |
| 7 | ADALIMUMAB | 3 |
| 8 | CANDESARTAN | 3 |
| 9 | CERTOLIZUMAB PEGOL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 8 | 0.0055 |
| 1 | ERLOTINIB HYDROCHLORIDE | 12 | 0.0010 |
| 2 | ZIPRASIDONE | 1 | 0.0003 |
| 3 | PENTOXIFYLLINE | 1 | 0.0002 |
| 4 | BEVACIZUMAB-AWWB | 1 | 0.0002 |
| 5 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 6 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | 1 | 0.0001 |
| 7 | ERGOCALCIFEROL | 3 | 0.0001 |
| 8 | CANDESARTAN | 3 | 0.0001 |
| 9 | CELECOXIB | 10 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Insulin [EPC] | 1 | 0.0000 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |